Just to echo Mr. Williams' point on that one, the philosophy—We have to remember that drugs today, as much as they represent a piece of the spending—it's somewhere between 4% to 8% of total public spending. There's still another 92% that's spent on other parts of the health system.
We have a philosophy in the rest of the health system, the trial of life, when we're dealing with severe needs, which is that you will put a patient in an ICU and give him the chance to see if it works. We don't do that with drugs.
Especially with new technologies that are coming out, with unmet needs that are out there where there is nothing else, what we do is we throw them into a CDR review and say let's take a look at it for a few months before we give the patients that choice and that option.
So we're saying if it's catastrophic in terms of life and the needs, then give them the chance.